-
The Safety of Methyl 6-quinolinecarboxylate
Time of Update: 2023-05-13
It is also important for workers to be trained in the safe handling and use of methyl 6-quinolinecarboxylate to ensure that they are aware of the potential risks and know how to prevent harm to themselves and others.
-
The Safety of 2-IODO-4-METHOXYPHENYLAMINE
Time of Update: 2023-05-11
By following proper handling and storage practices, wearing appropriate protective equipment, and providing proper training to employees, organizations can ensure the safe use of IOMPA.
By following proper handling and storage practices, wearing appropriate protective equipment, and providing proper training to employees, organizations can ensure the safe use of IOMPA.
-
【PNAS】Tsinghua Chen Mo Research Group: Composition mechanism of key transcription complexes of leukemia and new therapeutic targets
Time of Update: 2022-10-20
This study demonstrates that the AETFC complex recruits CARM1 to chromatin, thereby activating target gene expression and promoting AML cell survival, describing the novel role of the cancer transcription factor LYL1 in AETFC assembly and gene activation.
-
Molecular Cancer: Austrian researchers discover drivers of prostate cancer metastasis
Time of Update: 2022-04-18
The researchers from the Medical University of Vienna first analyzed the effect of Kmt2c SET domain deletion using a mouse model of prostate cancer, and then analyzed the effect of KMT2C truncating mutations in a large number of prostate cancer patients .
-
The Scottish Medicines Federation (SMC) approves the combination of Cabometyx/Opdivo for the treatment of patients with advanced kidney cancer
Time of Update: 2021-10-20
1 months , Cabometyx combined with Opdivo reduced the risk of death in patients with advanced RCC by 34% compared with the currently available sunitinib therapy .
-
Reduce the risk of bladder cancer death by 30% "first-in-class" ADC early termination of Phase 3 trials
Time of Update: 2020-10-10
in this clinical trial, Padcev significantly improved the overall survival of patients compared to the chemotherapy control group, reducing the risk of death by 30 percent (HR=0.70, 95 per cent CI:0.56,0.89, p=0.001).
-
Br J Cancer: Next-generation antibody-drug coupled is expected to treat KRAS mutant pancreatic cancer
Time of Update: 2020-10-04
synthesis of antibody-drug coupleds the study produced a highly refined ADC of anti-EGFR (the skin growth factor complex) by reconnectoring cetuximab (CTX) interchains of disulides with aristatin.
-
Axin Ubigenization degradation, which relies on SIHA, is a powerful speed limit step for maintaining the Wnt/beta-catenin signal
Time of Update: 2020-09-01
combined with in-cell knockout, molecular dynamics, and 3D structural studies, the researchers revealed that Axin Ubigenization degradation, which relies on SIHA, is a powerful speed-limiting step to maintain the Wnt/beta-catenin signal.
-
Dr. Hang Ta of the University of Queensland, Australia, is interested in enrolling Chinese Ph.D. students
Time of Update: 2020-08-24
Dr.Hang Ta、、,,。 ,,。 Dr Hang Ta,。 Dr.Hang Ta。 ,,。 ,：Biomaterials,Expert Opinionon Drug Deliver,Biomacromolecule。 ：PS:Dr Hang Tanice,。 。 AustralianInstitute for Bioengineering and Nanotechnology(AIBN)TheUniversity of QueenslandPhone:07 33463851Email:h.ta uq.edu.auResearchInterestsNanosensorsfor detecting and grading diseasesMolecularimaging/Diagnosis of cardiovascular diseaseNovelnanomaterials for theranostics of cardiovascular,inflammatory,and cancerousdiseasesNovelreversible blood clotting agentsNovel approaches in diagnosis andtreatment of cardiovascular diseaseDid you know that cardiovascular disease isAustralia’s greatest health problem.
-
Aishi and Mercadon's potential first-line combination therapy recognized by FDA breakthrough therapy
Time of Update: 2020-06-02
The designation of "breakthrough therapy" is an FDA policy designed to accelerate the development and review of drugs for the treatment of serious or life-threatening diseases To qualify for this desi
-
Surprise discovery! Immunotherapy may cause diabetes in cancer patients
Time of Update: 2020-06-02
Photo: Osaka University Pancreatic beta cells (insulin-producing) can trigger type 1 diabetes, and recent clinical studies of cancer patients have shown that ICIs can cause diabetes in some rare case
-
The first new drug of Globo h target! Taiwan Haoding antibody drug conjugate obi-999 launched the first human clinical research, treatment of a variety of solid tumors
Time of Update: 2019-12-19
December 19, 2019 / bioun / -- Taiwan Haoding Biotechnology Co., Ltd (Obi Pharma, Inc., hereinafter referred to as Haoding) recently announced the launch of a phase I / II clinical study (nct04084366)
-
Yahong medicine announced that all patients will be enrolled in apl-1202 phase III clinical trial in China
Time of Update: 2019-09-23
Arterial network (wechat: vcpeat) learned that on September 23, 2019, Yahong pharmaceutical, a global innovative drug R & D company focusing on the anti-tumor and related diseases of urogenital system
-
High fructose corn syrup can promote the growth of colorectal cancer
Time of Update: 2019-04-28
One of the factors contributing to the rise in obesity is the use of high fructose corn syrup (HFCS) as a sweetener in soft drinks Goncalves et al From Cornell Medical School in will found that HFCS c
